Second-line chemotherapy in advanced biliary cancer: a systematic review
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Second-line chemotherapy in advanced biliary cancer: a systematic review
Authors
Keywords
-
Journal
ANNALS OF ONCOLOGY
Volume 25, Issue 12, Pages 2328-2338
Publisher
Oxford University Press (OUP)
Online
2014-04-26
DOI
10.1093/annonc/mdu162
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Efficacy and safety of RAD001 in advanced biliary tract cancer (BTC) patients (pts) progressing after first-line chemotherapy: A phase II study.
- (2017) R. Buzzoni et al. JOURNAL OF CLINICAL ONCOLOGY
- A comparison of trends in mortality from primary liver cancer and intrahepatic cholangiocarcinoma in Europe
- (2013) P. Bertuccio et al. ANNALS OF ONCOLOGY
- FOLFIRI in patients with locally advanced or metastatic pancreatic or biliary tract carcinoma
- (2013) Roberto Moretto et al. ANTI-CANCER DRUGS
- Cancer statistics, 2013
- (2013) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- A multicenter phase II study of S-1 for gemcitabine-refractory biliary tract cancer
- (2013) Eiichiro Suzuki et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- A Retrospective Study of Gemcitabine and Cisplatin Combination Therapy as Second-Line Treatment for Advanced Biliary Tract Cancer
- (2013) Takashi Sasaki et al. CHEMOTHERAPY
- Improvement of prognosis for unresectable biliary tract cancer
- (2013) Takashi Sasaki WORLD JOURNAL OF GASTROENTEROLOGY
- Outcome of second-line chemotherapy for biliary tract cancer
- (2012) John Bridgewater et al. EUROPEAN JOURNAL OF CANCER
- Feasibility and benefits of second-line chemotherapy in advanced biliary tract cancer: A large retrospective study
- (2012) Thomas Walter et al. EUROPEAN JOURNAL OF CANCER
- A Retrospective Study of S-1 Monotherapy as Second-line Treatment for Patients with Advanced Biliary Tract Cancer
- (2012) S. Kobayashi et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Outcome of Infusional 5-Fluorouracil, Doxorubicin, and Mitomycin-C (iFAM) Chemotherapy and Analysis of Prognostic Factors in Patients with Refractory Advanced Biliary Tract Cancer
- (2012) Kyu-Hyoung Lim et al. ONCOLOGY
- A phase II study of sunitinib as a second-line treatment in advanced biliary tract carcinoma: A multicentre, multinational study
- (2011) Jun Ho Yi et al. EUROPEAN JOURNAL OF CANCER
- Phase II Trial of Erlotinib and Docetaxel in Advanced and Refractory Hepatocellular and Biliary Cancers: Hoosier Oncology Group GI06-101
- (2011) E. G. Chiorean et al. ONCOLOGIST
- Imatinib Mesylate for Palliative Second-Line Treatment of Advanced Biliary Tract Cancer: A Bicentric Phase II Study
- (2011) Annekathrin Roth et al. ONKOLOGIE
- Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: a comparative multicentre study in Japan
- (2010) T Okusaka et al. BRITISH JOURNAL OF CANCER
- Phase II study of second line gemcitabine single chemotherapy for biliary tract cancer patients with 5-fluorouracil refractoriness
- (2010) Sung Yong Oh et al. INVESTIGATIONAL NEW DRUGS
- Feasibility study of gemcitabine and cisplatin combination chemotherapy for patients with refractory biliary tract cancer
- (2010) Takashi Sasaki et al. INVESTIGATIONAL NEW DRUGS
- Multicenter phase II study of S-1 monotherapy as second-line chemotherapy for advanced biliary tract cancer refractory to gemcitabine
- (2010) Takashi Sasaki et al. INVESTIGATIONAL NEW DRUGS
- Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer
- (2010) Juan Valle et al. NEW ENGLAND JOURNAL OF MEDICINE
- Second-Line Treatment With a Combination of Continuous 5-Fluorouracil, Doxorubicin, and Mitomycin-C (Conti-Fam) in Gemcitabine-Pretreated Pancreatic and Biliary Tract Cancer
- (2009) Suee Lee et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Efficacy and safety of gemcitabine, oxaliplatin, and bevacizumab in advanced biliary-tract cancers and correlation of changes in 18-fluorodeoxyglucose PET with clinical outcome: a phase 2 study
- (2009) Andrew X Zhu et al. LANCET ONCOLOGY
- Capecitabine and Celecoxib as Second-Line Treatment of Advanced Pancreatic and Biliary Tract Cancers
- (2009) Maria S. Pino et al. ONCOLOGY
- S-1 Monotherapy in Patients with Advanced Biliary Tract Cancer
- (2009) Takashi Sasaki et al. ONCOLOGY
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
- (2009) David Moher et al. PLOS MEDICINE
- Phase II trial of oxaliplatin combined with leucovorin and fluorouracil for recurrent/metastatic biliary tract carcinoma
- (2008) Jae Yun Lim et al. ANTI-CANCER DRUGS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started